Author: Ahanchian, Hamid; Jones, Carmen M; Chen, Yueh-sheng; Sly, Peter D
Title: Respiratory viral infections in children with asthma: do they matter and can we prevent them? Document date: 2012_9_13
ID: 0mnsm6s4_10
Snippet: Much research interest has focused on the potential role respiratory viral infections play in the inception of asthma. It is well established that hospitalization for RSV bronchiolitis is a risk factor for asthma during childhood [37, 38] . Epidemiological studies have shown an increased risk of asthma with LRI caused by HRV. In the Childhood Origin of Asthma (COAST) birth cohort study, wheezing with RSV (odds ratio [OR], 2.6), HRV (OR, 9.8), or .....
Document: Much research interest has focused on the potential role respiratory viral infections play in the inception of asthma. It is well established that hospitalization for RSV bronchiolitis is a risk factor for asthma during childhood [37, 38] . Epidemiological studies have shown an increased risk of asthma with LRI caused by HRV. In the Childhood Origin of Asthma (COAST) birth cohort study, wheezing with RSV (odds ratio [OR], 2.6), HRV (OR, 9.8), or both HRV and RSV (OR, 10) was associated with increased asthma risk at age six years [7] . The Childhood Asthma Study (CAS) in Perth, Australia showed that wheezing with HRV or RSV in the first year of life was a risk factor (OR, 2.5) for current wheeze at five years of age [4] . Infant birth about four months before the winter virus peak carried the highest risk of developing asthma compared with birth 12 months before the peak [39] . The risk of asthma is increased by severe LRI (sLRI), especially in the presence of allergic sensitization in early life [4, 25] . There appears to be a synergistic interaction between viral infection and allergic sensitization, suggesting a "two hit" model for induction of persistent asthma. These data also provide a series of novel strategies for the primary prevention of asthma by prevention of either allergic sensitization or of sLRI in high risk children. This strategy is also supported in a study by Simoes et al. [40] , in which the use of palivizumab to prevent RSV infection decreased the risk of recurrent wheezing in nonatopic premature infants.
Search related documents:
Co phrase search for related documents- risk factor and RSV bronchiolitis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- risk factor and RSV bronchiolitis hospitalization: 1
- risk factor and RSV infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- risk factor and RSV infection prevent: 1
- risk factor and synergistic interaction: 1
- risk factor and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- risk factor and winter virus: 1, 2
- RSV bronchiolitis and synergistic interaction: 1
- RSV bronchiolitis and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- RSV bronchiolitis and winter virus: 1, 2, 3, 4, 5
- RSV bronchiolitis hospitalization and viral infection: 1
- RSV infection and synergistic interaction: 1
- RSV infection and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- RSV infection and winter virus: 1, 2, 3, 4, 5, 6, 7, 8
- RSV infection prevent and viral infection: 1, 2, 3, 4
- RSV infection prevent and winter virus: 1
- synergistic interaction and viral infection: 1, 2, 3
- viral infection and winter virus: 1, 2, 3, 4, 5, 6, 7, 8
- viral infection and winter virus peak: 1, 2
Co phrase search for related documents, hyperlinks ordered by date